Results 211 to 220 of about 6,876,355 (238)

Insurance Coverage and Access Requirements for Lower-Emission Inhalers in US Commercial Health Plans.

open access: yesJAMA Netw Open
Parthasarathi A   +5 more
europepmc   +1 more source

Budesonide/formoterol fumarate dihydrate <i>versus</i> budesonide with a novel suspension technology for uncontrolled asthma: phase 3 VATHOS study. [PDF]

open access: yesERJ Open Res
Jackson DJ   +12 more
europepmc   +1 more source

Reported use of anti-asthmatic medication in doping control forms from 2015 to 2019 - mapping retrospective data. [PDF]

open access: yesFront Sports Act Living
Kojen AJ   +5 more
europepmc   +1 more source

Abediterol (LAS100977), a novel long-acting β2-agonist: Efficacy, safety and tolerability in persistent asthma [PDF]

open access: yesRespiratory Medicine, 2014
SummaryBackgroundAbediterol (LAS100977) is a novel, long-acting β2-agonist, in development for the once-daily treatment of asthma in combination with mometasone.
J Beier, R Fuhr
exaly   +2 more sources

Home - About - Disclaimer - Privacy